Overview
- The genetically modified pig liver, transplanted as an auxiliary organ, produced bile and maintained blood flow without signs of rejection during the 10-day trial.
- The liver was sourced from a Bama miniature pig with six genetic modifications to reduce immune rejection and improve compatibility with humans.
- The procedure was conducted ethically, with family consent and approval from medical authorities, and was terminated at the family's request.
- This breakthrough, published in the journal Nature, highlights the potential of pig livers as temporary 'bridge' organs for patients awaiting human transplants.
- Researchers plan further studies, including trials on living patients and complete liver replacements, while addressing long-term functionality and ethical considerations.